Replies to post #53199 on Progressive Care Inc (fka RXMD)

[PersianMeow]

I think everything you said is valid in regards to investor sentiment. I am just watching this stock and comparing it to the folks previous past four months of posting. I think this month will be a indicator of whether this stock truly is a scam as previously assessed by some or an actual gem. I hope its a gem but I think it might be a dud.

[red13]

It is hard to expect a price jump driven by news of further operations improvement, regardless of the percentage gain or effects of the robot. There have been ample reports of sales and profit gains to boost share price. Nevertheless, PSR is less than 1 and continues to decline.

However, there are two things that are new on the horizon: an auditor's report and a move off the Pinks. If RXMD can publish an audited report by February and announce a target date for moving to QB, that should help expand the investor base, thus greater volume.

I think management can be forgiven to some degree for its lack of attention to share price to date. It's had a lot to worry about: getting to profitability, getting the robot up and running, etc.

It is now, however, high time for that lack of concern to end. Mars says she's getting "weekly" calls from interested suitors. If that's true, she should explain why interested companies have not simply begun buying up shares. There is some risk to that strategy, but if a peer or larger considered RXMD a gem, it should be able to buy a controlling interest without spiking the share price. (Around 30% of the vote could be acquired in three months or so at 1 million shares a day. Not difficult to do and still stay below fair value.)

I plan to stick around for 1Q 2017, as I do expect RXMD to come through on the audit and QB upgrade. If it does not, there appear to plenty of longs who have enough experience to cabal and exercise their voting power.

[Jimmy Quick]

I beg to differ. The company does care about the share price otherwise why would they ever spend the cash required to do quarterly reviews and a full audit of financials to uplist off of the pinks. Goal of mananagement is to improve the standing of this stock beyond the OTC, they did make some poor choices with shares for services that doesn't appear to have paid off for share price, but it did improve share price just not for the most recent shareholders, cleared debt, and now it has settled, but anyone who has patience will be rewarded in 2017 and much more beyond that.

I like how some try to spit on 30% net revenue growth. They do that again next year and we are at 25 million net revenue. Do you know how hard that is in our competitive sector. The margins were smaller because we offer services no other pharmacies offer that has spurred that growth. That's why they started Smart Medical Alliance, that is the division of Progressive that offers extra services that we were providing for free that they are now charging a fee for services for. If profitability comes from this then they will have been successful on capitalizing on this and increasing operating profits.

Management does need to curtail shares for services in the future. Chicago Ventures in my opinion will never receive a share of RXMD unless we complete a M&A. Here's to 2017. Cheers RXMD investors and good luck to you all.